These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15701452)

  • 21. Informatics solutions for high-throughput proteomics.
    Topaloglou T
    Drug Discov Today; 2006 Jun; 11(11-12):509-16. PubMed ID: 16713902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics: recent applications and new technologies.
    Elrick MM; Walgren JL; Mitchell MD; Thompson DC
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):432-41. PubMed ID: 16635100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biophysical techniques for ligand screening and drug design.
    Renaud JP; Delsuc MA
    Curr Opin Pharmacol; 2009 Oct; 9(5):622-8. PubMed ID: 19581126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latest technologies for the enhancement of antibody affinity.
    Wark KL; Hudson PJ
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):657-70. PubMed ID: 16828920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRISM: a data management system for high-throughput proteomics.
    Kiebel GR; Auberry KJ; Jaitly N; Clark DA; Monroe ME; Peterson ES; Tolić N; Anderson GA; Smith RD
    Proteomics; 2006 Mar; 6(6):1783-90. PubMed ID: 16470653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplexed PrEST immunization for high-throughput affinity proteomics.
    Larsson K; Wester K; Nilsson P; Uhlén M; Hober S; Wernérus H
    J Immunol Methods; 2006 Aug; 315(1-2):110-20. PubMed ID: 16949094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discovery.
    Geuijen CA; Clijsters-van der Horst M; Cox F; Rood PM; Throsby M; Jongeneelen MA; Backus HH; van Deventer E; Kruisbeek AM; Goudsmit J; de Kruif J
    J Immunol Methods; 2005 Jul; 302(1-2):68-77. PubMed ID: 15992810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-level generation of polyclonal antibodies by genetic immunization.
    Chambers RS; Johnston SA
    Nat Biotechnol; 2003 Sep; 21(9):1088-92. PubMed ID: 12910245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of recombinant antibody microarrays for cell surface membrane proteomics.
    Dexlin L; Ingvarsson J; Frendéus B; Borrebaeck CA; Wingren C
    J Proteome Res; 2008 Jan; 7(1):319-27. PubMed ID: 18047267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibody proteomics: discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step.
    Csanky E; Olivova P; Rajnavolgyi E; Hempel W; Tardieu N; Katalin ET; Jullien A; Malderez-Bloes C; Kuras M; Duval MX; Nagy L; Scholtz B; Hancock W; Karger B; Guttman A; Takacs L
    Electrophoresis; 2007 Dec; 28(23):4401-6. PubMed ID: 18041035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HepatoProteomics: applying proteomic technologies to the study of liver function and disease.
    Diamond DL; Proll SC; Jacobs JM; Chan EY; Camp DG; Smith RD; Katze MG
    Hepatology; 2006 Aug; 44(2):299-308. PubMed ID: 16871559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody arrays--an emerging tool in cancer proteomics.
    Kopf E; Zharhary D
    Int J Biochem Cell Biol; 2007; 39(7-8):1305-17. PubMed ID: 17600752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein biochips: A new and versatile platform technology for molecular medicine.
    Lueking A; Cahill DJ; Müllner S
    Drug Discov Today; 2005 Jun; 10(11):789-94. PubMed ID: 15922937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.
    Fellouse FA; Esaki K; Birtalan S; Raptis D; Cancasci VJ; Koide A; Jhurani P; Vasser M; Wiesmann C; Kossiakoff AA; Koide S; Sidhu SS
    J Mol Biol; 2007 Nov; 373(4):924-40. PubMed ID: 17825836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cancer protein microarray platform using antibody fragments and its clinical applications.
    Song S; Li B; Wang L; Wu H; Hu J; Li M; Fan C
    Mol Biosyst; 2007 Feb; 3(2):151-8. PubMed ID: 17245494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic resources: integrating biomedical information in humans.
    Suresh S; Sujatha Mohan S; Mishra G; Hanumanthu GR; Suresh M; Reddy R; Pandey A
    Gene; 2005 Dec; 364():13-8. PubMed ID: 16202541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human protein atlas based on antibody proteomics.
    Persson A; Hober S; Uhlén M
    Curr Opin Mol Ther; 2006 Jun; 8(3):185-90. PubMed ID: 16774037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Label-free mass spectrometry-based protein quantification technologies in proteomic analysis.
    Wang M; You J; Bemis KG; Tegeler TJ; Brown DP
    Brief Funct Genomic Proteomic; 2008 Sep; 7(5):329-39. PubMed ID: 18579615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural proteomics in drug discovery.
    Tari LW; Rosenberg M; Schryvers AB
    Expert Rev Proteomics; 2005 Aug; 2(4):511-9. PubMed ID: 16097885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.